Safety of Abrocitinib in 3582 Patients With Moderate-to-Severe Atopic Dermatitis With Over 900 Patients Exposed for Almost 2 Years. J of Skin [Internet]. 2023 Mar. 13 [cited 2025 Apr. 19];7(2):s150. Available from: https://skin.dermsquared.com/skin/article/view/1989